Clinical Trial Results:
A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 vs capecitabine (Xeloda™ ) in Patients with Colorectal Cancer who have Failed Two Prior Chemotherapeutic Regimens.
Summary
|
|
EudraCT number |
2006-001457-10 |
Trial protocol |
SE ES HU SK |
Global completion date |
01 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Sep 2016
|
First version publication date |
29 Sep 2016
|
Other versions |
|
Summary report(s) |
CSR_D1532C00011 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.